| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Aug―28 |
MM-1155: Peculiarities of Course and Prophylaxis of Coronavirus Infection in Patients With Multiple Myeloma |
Daria Chebikina, A Koviazin, I Krobinets DrMedSc |
| 2 |
[GO] |
2025―Aug―28 |
POSTER: MM-1155 Peculiarities of Course and Prophylaxis of Coronavirus Infection in Patients With Multiple Myeloma |
Daria Chebikina, A Koviazin, I Krobinets DrMedSc |
| 3 |
[GO] |
2025―Aug―28 |
POSTER: MM-1227 Multiple Myeloma and COVID-19: Trends in Mortality in the United States From 1999 to 2022 |
Mahnoor Fatima, Shamikha Cheema, Denish Kumar, Iqra Shahid, Ahmed Raza, Faiza Fatima, Iman Ahmed, Hasan Ijaz, Umaima Cheema, Fatima Tuz Zahra, Utsav Joshi |
| 4 |
[GO] |
2025―Aug―28 |
MM-1227: Multiple Myeloma and COVID-19: Trends in Mortality in the United States From 1999 to 2022 |
Mahnoor Fatima, Shamikha Cheema, Denish Kumar, Iqra Shahid, Ahmed Raza, Faiza Fatima, Iman Ahmed, Hasan Ijaz, Umaima Cheema, Fatima Tuz Zahra, Utsav Joshi |
| 5 |
[GO] |
2025―Aug―28 |
POSTER: AML-845 COVID-19-Associated Hemophagocytic Lymphohistiocytosis: A Nationwide Analysis 2017-2021 |
Barath Sivasubramanian, Gagan Kumar, Achuta Kumar Guddati |
| 6 |
[GO] |
2025―Aug―28 |
AML-845: COVID-19-Associated Hemophagocytic Lymphohistiocytosis: A Nationwide Analysis 2017-2021 |
Barath Sivasubramanian, Gagan Kumar, Achuta Kumar Guddati |
| 7 |
[GO] |
2025―Aug―28 |
POSTER: AML-715 How COVID-19 Shaped Acute Myeloid Leukemia Mortality Among Older Adults in the United States |
Shehroz Yar Khan, Farhan Israr, Iqbal Hussain, Aamer Ahmad, Aqib Latif, Sadaf Marjan, Zarlish Farooq |
| 8 |
[GO] |
2025―Aug―28 |
AML-715: How COVID-19 Shaped Acute Myeloid Leukemia Mortality Among Older Adults in the United States |
Shehroz yar Khan, Farhan Israr, Iqbal Hussain, Aamer Ahmad, Aqib Latif, Sadaf Marjan, Zarlish Farooq |
| 9 |
[GO] |
2025―Aug―28 |
ALL-500: Factors Associated With COVID-19, Influenza, and Pneumococcal Vaccination in Survivors of Hematologic Malignancies |
Rita Ahmad, Seth Maliske, Abe Sahmoun |
| 10 |
[GO] |
2025―Aug―28 |
POSTER: ALL-500 Factors Associated With COVID-19, Influenza, and Pneumococcal Vaccination in Survivors of Hematologic Malignancies |
Rita Ahmad, Seth Maliske, Abe Sahmoun |
| 11 |
[GO] |
2025―Aug―28 |
POSTER: CLL-105 COVID-19 Infection Outcome in a Subgroup of Patients With Unmutated IGHV1-69 Chronic Lymphocytic Leukemia: A Single-Center Experience |
Sanja Trajkova, S Krstevska Balkanov, A Pivkova Veljanovska, N Ridova, Z Stojanovski, S Stojanovska Jakimovska, M Cvetanovski, T Mojsoska, B Kocoski, L Cadievski, A Paunoska, M Purde, I Panovska Stavridis |
| 12 |
[GO] |
2025―Aug―28 |
CLL-105: COVID-19 Infection Outcome in a Subgroup of Patients With Unmutated IGHV1-69 Chronic Lymphocytic Leukemia: A Single-Center Experience |
Sanja Trajkova, S Krstevska Balkanov, A Pivkova Veljanovska, N Ridova, Z Stojanovski, S Stojanovska Jakimovska, M Cvetanovski, T Mojsoska, B Kocoski, L Cadievski, A Paunoska, M Purde, I Panovska Stavridis |
| 13 |
[GO] |
2025―Aug―28 |
ABCL-261: Repercussions of COVID-19 Infection on Evolution of Non-Hodgkin Lymphomas |
Vasile Musteata, Valeria Muntean, Larisa Musteata, Dumitrita Urescu, Nina Sghibneva-Bobeico, Irina Cebanu |
| 14 |
[GO] |
2025―Aug―28 |
POSTER: MM-1069 Clinical Outcomes and Mortality Predictors in Multiple Myeloma Hospitalizations With COVID-19 Infection |
Ayobami Olafimihan, Ferdinand Ugwuja, Olanipekun Lanny Ntukidem, Lina James George, Youjin Oh, Esther Ade-Adeleye |
| 15 |
[GO] |
2025―Aug―28 |
MM-1069: Clinical Outcomes and Mortality Predictors in Multiple Myeloma Hospitalizations With COVID-19 Infection |
Ayobami Olafimihan, Ferdinand Ugwuja, Olanipekun Lanny Ntukidem, Lina James George, Youjin Oh, Esther Ade-Adeleye |
| 16 |
[GO] |
2025―Feb―15 |
Antibody response to Pneumococcal, Influenza, and COVID-19 vaccination in patients with Multiple Myeloma |
Pranjal Singh, Charanpreet Singh, Kamaljeet Kamaljeet, VA Arun, RK Ratho, Archana Angrup, Arihant Jain, Sreejesh Sreedharanunni, Gaurav Prakash, Alka Khadwal, Pankaj Malhotra |
| 17 |
[GO] |
2024―Nov―29 |
Artificial Intelligence Assessment of Chest Radiographs for COVID-19 |
Koji Sasaki, Guillermo Garcia-Manero, Masayuki Nigo, Elias Jabbour, Farhad Ravandi, William G. Wierda, Nitin Jain, Koichi Takahashi, Guillermo Montalban-Bravo, Naval G. Daver, Philip A. Thompson, Naveen Pemmaraju, Dimitrios P. Kontoyiannis, Junya Sato, Sam Karimaghaei, Kelly A. Soltysiak, Issam I. Raad, Hagop M. Kantarjian, Brett W. Carter |
| 18 |
[GO] |
2024―Sep―24 |
P-046 Identifying immune checkpoints on dysregulated T-cells as prognostic biomarkers for multiple myeloma patients with COVID-19 |
Ziping Li, Huiwen He, Fujing Zhang, Xianghong Jin, Yuhang Song, Shuangjiao Liu, Xuan Wang, Junling Zhuang |
| 19 |
[GO] |
2024―Sep―24 |
P-089 Impact of COVID-19 on Outcomes With Teclistamab in the Phase 1/2 MajesTEC-1 Study in Patients With Relapsed/Refractory Multiple Myeloma |
Saad Usmani, Nizar J. Bahlis, Luciano Costa, María-Victoria Mateos Manteca, Ajay Nooka, Aurore Perrot, Pragya Thaman, Keqin Qi, Clarissa Uhlar, Katherine Chastain, Margaret Doyle, Niels van de Donk |
| 20 |
[GO] |
2024―Aug―26 |
MM-289 Exosomal Vesicles as a Promising Strategy for Severe COVID-19 in Multiple Myeloma Patients |
Yan Nouet, Muskan Joshi, Viviana Cortiana, Gayathri Pramil, Alexandra van de Kieft, Chandler H. Park |
| 21 |
[GO] |
2024―Aug―26 |
MDS-242 Correlation Between Myelodysplastic Syndrome and COVID-19 Infection |
Rana G. Abdelfatah, Salma Abdelghany Shawkat, Menna Abdelghany Ali, Enaam Ali Al Mwafy, Nermine Moheb Mettias |
| 22 |
[GO] |
2024―Aug―26 |
AML-230 The Impact of COVID-19 on Acute Myeloid Leukemia (AML): A Propensity Matched Analysis |
Barath Prashanth Sivasubramanian, Diviya Bharathi Ravikumar, Abul Hasan Shadali Abdul Khader, Ibthisam Ismail Sharieff, Tenzin Tamdin, Raghavendra Tirupathi, Mamtha Balla |
| 23 |
[GO] |
2024―Aug―26 |
AML-045 Impact of COVID-19 on the Clinical Characteristics and Outcomes of Patients With Acute Leukemias: An Academic Center Experience |
Al Yaqadhan Al Kindi, Thuraya Al-Busaidi, Yahya Al-Kindi, Fatma Al-Bulushi, Mohamed Al-Hanini, Maryam Al-Bakri, Murtadha Al-Khabori |
| 24 |
[GO] |
2024―Aug―26 |
MM-593 Sociodemographic Trends in Multiple Myeloma-Related Mortality From 1999 to 2020 and Effect of the COVID-19 Pandemic |
Parisa Aijaz, Hira Shaikh, Amir Kamran |
| 25 |
[GO] |
2024―Aug―26 |
TCL-760 Hemophagocytic Lymphohistiocytosis in COVID-19: A Retrospective Analysis of Risks, Outcomes, and Health Care Burden in US Hospitals |
Dharmik Patel, Rushin Patel, Adit Dharia, Mrunal Patel, Darshil Patel, Zalak Patel, Sanskruti Patel, Vyom Patel, Chieh Yang, Salman Muddassir |
| 26 |
[GO] |
2024―Aug―26 |
Sociodemographic Trends in Multiple Myeloma-Related Mortality From 1999 to 2020 and Effect of the COVID-19 Pandemic |
Parisa Aijaz, Hira Shaikh, Amir Kamran |
| 27 |
[GO] |
2024―Aug―26 |
MM-761 Multiple Myeloma Mortality Trends Before Pandemic, Stratified by Year Sex, and Race: 1999-2019 |
Muhammad Faisal Aslam, Muhammad Faisal Aslam |
| 28 |
[GO] |
2024―Aug―26 |
Multiple Myeloma Mortality Trends Before Pandemic, Stratified by Year, Sex, and Race: 1999-2019 |
Muhammad Faisal Aslam, Muhammad Hisham Khan Wazir |
| 29 |
[GO] |
2024―Aug―26 |
Exosomal Vesicles as a Promising Strategy for Severe COVID-19 in Multiple Myeloma Patients |
Yan Leyfman, Muskan Joshi, Viviana Cortiana, Gayathri Pramil, Alexandra van de Kieft, Chandler H. Park |
| 30 |
[GO] |
2024―Aug―26 |
Correlation Between Myelodysplastic Syndrome and COVID-19 Infection |
Rana G. Abdelfatah, Salma Abdelghany Shawkat, Menna Abdelghany Ali, Enaam Ali Al Mwafy, Nermine Moheb Mettias |
| 31 |
[GO] |
2024―Aug―26 |
The Impact of COVID-19 on Acute Myeloid Leukemia (AML): A Propensity Matched Analysis |
Barath Prashanth Sivasubramanian, Diviya Bharathi Ravikumar, Abul Hasan Shadali Abdul Khader, Ibthisam Ismail Sharieff, Tenzin Tamdin, Raghavendra Tirupathi, Mamtha Balla |
| 32 |
[GO] |
2024―Aug―26 |
Hemophagocytic Lymphohistiocytosis in COVID-19: A Retrospective Analysis of Risks, Outcomes, and Health Care Burden in US Hospitals |
Dharmik Patel, Rushin Patel, Adit Dharia, Mrunal Patel, Darshil Patel, Zalak Patel, Sanskruti Patel, Vyom Patel, Chieh Yang, Salman Muddassir |
| 33 |
[GO] |
2024―Jan―21 |
Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy: A Prospective Cohort Study |
Alexandra Hillyer, Anthony Quint, Artin Ghassemian, Nicolette Joh-Carnella, Michael J. Knauer, Danny Dawd, Alejandro Lazo-Langner, Joy Mangel, Selay Lam, Husam Abdoh, Anargyros Xenocostas, Uday Deotare, Lalit Saini, Cheryl Foster, Martha Louzada, Jenny Ho, Ian Chin Yee, Chai W. Phua |
| 34 |
[GO] |
2023―Sep―26 |
P-469 Observational study of COVID-19 prophylactic antibody (tixagevimab/cilgavimab) administration for multiple myeloma patients |
Yoojin Lee, Jae-Cheol Jo |
| 35 |
[GO] |
2023―Sep―26 |
P-378 Longitudinal antibody and T-cell kinetics over four doses of COVID-19 vaccination and predictors of poor response in patients with multiple myeloma |
Gaurav Agarwal, Sally Moore, Ross Sadler, Sherin Varghese, Alison Turner, Lucia Chen, Jemma Larham, Nathanael Gray, Oluremi Carty, Joe Barrett, Constantinos Koshiaris, Stella Bowcock, Udo Oppermann, Vicki Gamble, Gordon Cook, Charalampia Kyriakou, Mark Drayson, Supratik Basu, Sarah McDonald, Shelagh McKinley, Sarah Gooding, Muhammad Javaid, Karthik Ramasamy |
| 36 |
[GO] |
2023―Sep―26 |
P-400 An immune atlas of the dysfunctional cellular and antibody response to COVID-19 vaccination in patients with multiple myeloma |
Esperanza Martin-Sanchez, Camila Guerrero, Luis-Esteban Tamariz-Amador, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesús San-Miguel, Paula Rodriguez-Otero, Bruno Paiva, Asociación Vasco-Navarra de Hematología y Hemoterapia (ASOVASNA) |
| 37 |
[GO] |
2023―Sep―26 |
P-393 COVID-19 vaccine acceptance/hesitancy and influence on infection in patients with multiple myeloma: a national-wide multicenter survey in China |
Huiwen He, Ziping Li, Shuangjiao Liu, Wenming Chen, Wanling Sun, Baolai Hua, Yongzhe Li, Junling Zhuang |
| 38 |
[GO] |
2023―Sep―26 |
P-477 Pre-exposure prophylaxis for COVID-19 with tixagevimab/cilgavimab (evusheld) in patients with multiple myeloma in the omicron SARS-COV-2 era |
Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Vassiliki Spiliopoulou, Rodanthi-Eleni Syrigou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Efstathios Kastritis, Meletios Dimopoulos, Evangelos Terpos |
| 39 |
[GO] |
2023―Sep―26 |
P-379 Variable humoral and cellular responses to SARS-CoV-2 bivalent booster vaccination in patients with multiple myeloma |
Adolfo Aleman, Morgan van Kesteren, Ariel Kogan-Zajdman, Bhaskar Upadhyaya, Lucia Chen, Annika Oostenink, Kseniya Serebryakova, Komal Srivastava, Katerina Kappes, Hayley Jackson, Charles Gleason, Juan Manuel Carreño Quiroz, Seronet Study Group, Carlos Cordon-Cardo, Ania Wajnberg, Florian Krammer, Sundar Jagannath, Viviana Simon, Samir Parekh |
| 40 |
[GO] |
2023―Sep―26 |
P-398 Dynamic immune response in multiple myeloma patients infected with SARS-CoV-2 omicron BA.4/5 subvariant in China |
Ziping Li, Huiwen He, Haolong Li, Shuangjiao Liu, Fujing Zhang, Yongzhe Li, Junling Zhuang |
| 41 |
[GO] |
2023―Aug―31 |
ABCL-529 The Difference in Mortality, Seroconversion, and Duration of Hospitalization Between Patients With and Without Anti-CD20 Antibody Therapy Among Hematological Malignancies With Superadded COVID-19 Infection |
Charan Thej Reddy Vegivinti, Rahul Thakur, Jeevan Shivakumar, M Bakri Hammami, Mansi Mehta, Jaison Lawrence Alexander Santhi, Lakshmi Pappoppula, Pranesh Siruvalur Elango, Venkata Kiranmayi Kakumani, Thulasi Ram Gudi, Murali Mohan Reddy Gopireddy, Nagarathna Poojary, Ananta Ghimire, Praneeth Reddy Kesari, Nikita Chintapally, Tejo Niharika Musunuru |
| 42 |
[GO] |
2023―Aug―31 |
POSTER: ABCL-529 The Difference in Mortality, Seroconversion, and Duration of Hospitalization Between Patients With and Without Anti-CD20 Antibody Therapy Among Hematological Malignancies With Superadded COVID-19 Infection |
Charan Thej Reddy Vegivinti, Rahul Thakur, Jeevan Shivakumar, M Bakri Hammami, Mansi Mehta, Jaison Lawrence Alexander Santhi, Lakshmi Pappoppula, Pranesh Siruvalur Elango, Venkata Kiranmayi Kakumani, Thulasi Ram Gudi, Murali Mohan Reddy Gopireddy, Nagarathna Poojary, Ananta Ghimire, Praneeth Reddy Kesari, Nikita Chintapally, Tejo Niharika Musunuru |
| 43 |
[GO] |
2023―Aug―31 |
MM-126 The Invisible Damage of the COVID-19 Pandemic to Our Apheresia Unit and the National Economy |
Gülşah Akyol, Mustafa Baydar, Serpil Baysal, Muzaffer Keklik, Ali Ünal |
| 44 |
[GO] |
2023―Aug―31 |
CT-150 COVID-19 Vaccination-Associated Acquired Thrombotic Thrombocytopenic Purpura (TTP) |
Ruveyda Silay, Nigar Taghiyeva, Simge Erdem, Mustafa Nuri Yenerel |
| 45 |
[GO] |
2023―Aug―31 |
POSTER: CT-150 COVID-19 Vaccination-Associated Acquired Thrombotic Thrombocytopenic Purpura (TTP) |
Ruveyda Silay, Nigar Taghiyeva, Simge Erdem, Mustafa Nuri Yenerel |
| 46 |
[GO] |
2023―Aug―31 |
CML-084 COVID-19 - Trigger for Chronic Myeloid Leukemia Evolution? |
Viola Popov, Mihaela Andreescu |
| 47 |
[GO] |
2023―Aug―31 |
IBCL-057 Incidence and Features of SARS-CoV-2 Breakthrough Infection in the Hematological Conditions After Tixagevimab-Cilgavimab Prophylaxis |
Andrea Duminuco, Antonella Nardo, Alessandra Orofino, Giuliana Giunta, Concetta Conticello, Vittorio Del Fabro, Amalia Figuera, Annalisa Chiarenza, Giuseppe Milone, Salvatore Leotta, Alessandra Cupri, Marina Parisi, Elisa Mauro, Calogero Vetro, Francesco Di Raimondo, Alessandra Romano, Giuseppe A. Palumbo |
| 48 |
[GO] |
2023―Aug―31 |
POSTER: IBCL-057 Incidence and Features of SARS-CoV-2 Breakthrough Infection in the Hematological Conditions After Tixagevimab-Cilgavimab Prophylaxis |
Andrea Duminuco, Antonella Nardo, Alessandra Orofino, Giuliana Giunta, Concetta Conticello, Vittorio Del Fabro, Amalia Figuera, Annalisa Chiarenza, Giuseppe Milone, Salvatore Leotta, Alessandra Cupri, Marina Parisi, Elisa Mauro, Calogero Vetro, Francesco Di Raimondo, Alessandra Romano, Giuseppe A. Palumbo |
| 49 |
[GO] |
2023―Aug―31 |
IBCL-265 Compassionate Use of Plitidepsin in Patients With Non-Hodgkin Lymphoma (NHL) and SARS-CoV-2 Infection |
Alicia Ortiz Lopez, Elena Saiz Lou, Raquel Lloris Fernandez, Diego Lopez Mendoza, Raquel de la Oña, Monica Estevez, Rebeca Iglesias, Patricia Zoilo, Carlos Montalban, Adolfo de la Fuente Burguera |
| 50 |
[GO] |
2023―Aug―31 |
POSTER: IBCL-265 Compassionate Use of Plitidepsin in Patients With Non-Hodgkin Lymphoma (NHL) and SARS-CoV-2 Infection |
Alicia Ortiz Lopez, Elena Saiz Lou, Raquel Lloris Fernandez, Diego Lopez Mendoza, Raquel de la Oña, Monica Estevez, Rebeca Iglesias, Patricia Zoilo, Carlos Montalban, Adolfo de la Fuente Burguera |
| 51 |
[GO] |
2023―Aug―31 |
CML-425 Evaluation of Antibody Responses among Five Different SARS-Cov-2 Vaccines in Chronic Myeloid Leukemia (CML) Patients - A Real-World Study |
Ana Toreli, Marisol Miranda-Galvis, Marcelo Addas-Carvalho, Eliana Miranda, Leonardo Fechio, Adriana Duarte, Audrey Basso, Gislaine Duarte, Samuel Medina, Fernando Pericole, Bruno Benites, Ravindra Kolhe, Kimya Jones, Harmanpreet Singh, Sara Teresinha Olalla Saad, Carmino Antonio de Souza, Jorge Cortes, Katia Pagnano |
| 52 |
[GO] |
2023―Aug―31 |
POSTER: CML-425 Evaluation of Antibody Responses among Five Different SARS-Cov-2 Vaccines in Chronic Myeloid Leukemia (CML) Patients - A Real-World Study |
Ana Toreli, Marisol Miranda-Galvis, Marcelo Addas-Carvalho, Eliana Miranda, Leonardo Fechio, Adriana Duarte, Audrey Basso, Gislaine Duarte, Samuel Medina, Fernando Pericole, Bruno Benites, Ravindra Kolhe, Kimya Jones, Harmanpreet Singh, Sara Teresinha Olalla Saad, Carmino Antonio de Souza, Jorge Cortes, Katia Pagnano |
| 53 |
[GO] |
2023―Apr―28 |
Risk and Severity of COVID-19 Infection in Monoclonal Gammopathy of Undetermined Significance: A 3-Year Propensity Matched Cohort Study |
Omer S Ashruf, Zara Orozco, David C Kaelber |
| 54 |
[GO] |
2023―Apr―14 |
CLINICAL OUTCOMES IN PATIENTS WITH COVID-19 AND HEMATOLOGIC DISEASE |
Olga A. Aleshina, Kristina Zakurdaeva, Anastasia N. Vasileva, Sergey K. Dubov, Vitaly S. Dubov, Vladimir I. Vorobyev, Lev S. Butaev, Alena M. Sukhareva, Lubov V. Gavrilova, Inessa Yu. Toropova, Marina O. Popova, Aleksandr A. Siniaev, Aleksandr D. Kulagin, Kamil D. Kaplanov, Andrei A. Petrenko, Oksana I. Ochirova, Alina Karpova, Ekaterina Yu. Chelysheva, Anna G. Turkina, Margarita A. Gurianova, Liubov S. Al-Radi, Elena A. Gilyazitdinova, Elena K. Egorova, Yulia A. Chabaeva, Sergey M. Kulikov, Yulia V. Sveshnikova, Mikhail A. Kunst, Vasily Shuvaev, Anzhelika F. Rakhmani, Olga L. Panteleeva, Maria E. Grishunina, Olga S. Samoylova, Ekaterina Vorontsova, Daria V. Baryshnikova, Elena N. Parovichnikova |
| 55 |
[GO] |
2023―Mrz―07 |
Response to COVID-19 vaccination post CAR T therapy in patients with non-Hodgkin lymphoma and multiple myeloma |
Julia E. Wiedmeier-Nutor, Madiha Iqbal, Allison C. Rosenthal, Evandro D. Bezerra, Juan Esteban Garcia-Robledo, Radhika Bansal, Patrick B. Johnston, Matthew Hathcock, Jeremy T. Larsen, P. Leif Bergsagel, Yucai Wang, Craig B. Reeder, Jose F. Leis, Rafael Fonseca, Jeanne M. Palmer, Brianna J. Gysbers, Raphael Mwangi, Rahma M Warsame, Taxiarchis Kourelis, Suzanne R. Hayman, David Dingli, Prashant Kapoor, Shaji K Kumar, Urshila Durani, Jose C. Villasboas, Jonas Paludo, N. Nora Bennani, Greg Nowakowski, Stephen M. Ansell, Januario E Castro, Mohamed A. Kharfan-Dabaja, Yi Lin, Paschalis Vergidis, Hemant S. Murthy, Javier Munoz |
| 56 |
[GO] |
2023―Jan―18 |
Retrospective review of outcomes of Multiple Myeloma (MM) patients with COVID-19 infection (two-center study) |
Hamid Ehsan, Alec Britt, Peter M Voorhees, Barry Paul, Manisha Bhutani, Cindy Varga, Zane Chiad, Brittany K. Ragon, Al-Ola A. Abdallah, Nausheen Ahmed, Shebli Atrash |
| 57 |
[GO] |
2022―Sep―21 |
Poster: TCL-458 Real-World Treatment Patterns in Patients With Sézary Syndrome in the United States and the Impact of Covid-19 |
Yang Zhao, Jackson Tang, Huanxue Zhou, Takeshi Takahashi, Takanobu Nomura, Eslie Dennis, Oleg Akilov |
| 58 |
[GO] |
2022―Sep―21 |
TCL-458 Real-World Treatment Patterns in Patients With Sézary Syndrome in the United States and the Impact of Covid-19 |
Yang Zhao, Jackson Tang, Huanxue Zhou, Takeshi Takahashi, Takanobu Nomura, Eslie Dennis, Oleg Akilov |
| 59 |
[GO] |
2022―Sep―21 |
CML-127 Results of a Vaccination Against COVID-19 by a Vector Based Vaccine Sputnik V in Patients With Chronic Myeloid Leukemia |
Ekaterina Chelysheva, Anna Petrova, Margarita Gurianova, Oleg Shukhov, Anastasia Bykova, Irina Nemchenko, Dmitry Tikhomirov, Hunan Julhakyan, Alina Kokhno, Anna Turkina |
| 60 |
[GO] |
2022―Sep―21 |
Poster: CML-127 Results of a Vaccination Against COVID-19 by a Vector Based Vaccine Sputnik V in Patients With Chronic Myeloid Leukemia |
Ekaterina Chelysheva, Anna Petrova, Margarita Gurianova, Oleg Shukhov, Anastasia Bykova, Irina Nemchenko, Dmitry Tikhomirov, Hunan Julhakyan, Alina Kokhno, Anna Turkina |
| 61 |
[GO] |
2022―Sep―21 |
AML-174 Dilemma of Treating Acute Myeloid Leukemia Patient After Kidney Transplant in the COVID-19 Era |
Shaimaa El-Ashwah, Esraa Jamal, Ahmed ELazab, May Denewer, Metwaly Ibrahim Mortada, Mayada A. Ghannam, Nihal M Batouty, Salma Elashwah, Ziad Emarah, Eman Mohamed Ibrahim, Mohamed G. Mansour, Emad Azmy, Mohamed Mabed, Sameh Shamaa |
| 62 |
[GO] |
2022―Sep―21 |
ALL-206 Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country |
Mahmoud Hammad, Lobna Shalaby, Iman Sidhom, Nancy Sherief, Ibrahim Abdo, Sonia Soliman, Youssef Madeny, Reem Hassan, Shaimaa Elmeniawy, Nagwa Khamis, Iman Zaki, Tarek Mansour, Mohamed Gamal El-Ansary, Ahmed El-Halfawy, Sherif Abouelnaga, Alaa Elhaddad |
| 63 |
[GO] |
2022―Sep―21 |
Poster: ALL-206 Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country |
Mahmoud Hammad, Lobna Shalaby, Iman Sidhom, Nancy Sherief, Ibrahim Abdo, Sonia Soliman, Youssef Madeny, Reem Hassan, Shaimaa Elmeniawy, Nagwa Khamis, Iman Zaki, Tarek Mansour, Mohamed Gamal El-Ansary, Ahmed El-Halfawy, Sherif Abouelnaga, Alaa Elhaddad |
| 64 |
[GO] |
2022―Sep―21 |
TCL-456 Real-World Use of Mogamulizumab among Patients With Mycosis Fungoides and Sézary Syndrome Before and During COVID-19 in the United States |
Yang Zhao, Jackson Tang, Huanxue Zhou, Takeshi Takahashi, Takanobu Nomura, Eslie Dennis, Ahmad Halwani |
| 65 |
[GO] |
2022―Sep―21 |
Poster: TCL-456 Real-World Use of Mogamulizumab among Patients With Mycosis Fungoides and Sézary Syndrome Before and During COVID-19 in the United States |
Yang Zhao, Jackson Tang, Huanxue Zhou, Takeshi Takahashi, Takanobu Nomura, Eslie Dennis, Ahmad Halwani |
| 66 |
[GO] |
2022―Sep―21 |
CLL-033 Is COVID-19 Infection a Trigger for Progression of CLL? |
Viola Popov, Horia Bumbea, Mihaela Andreescu, Geanina Ofiteru, Felicia Mihai, Mihaela Popescu, Oana Patrinoiu, Daniela Georgescu, Claudia Despan, Meilin Omer |
| 67 |
[GO] |
2022―Sep―21 |
Poster: CLL-033 Is COVID-19 Infection a Trigger for Progression of CLL? |
Viola Popov, Horia Bumbea, Mihaela Andreescu, Geanina Ofiteru, Felicia Mihai, Mihaela Popescu, Oana Patrinoiu, Daniela Georgescu, Claudia Despan, Meilin Omer |
| 68 |
[GO] |
2022―Sep―21 |
ALL-083 ALLogeneic Hematopoietic Stem Cell Transplantation of a R/R T-ALL Patient Given Nelarabine, 3 Weeks Post Moderate COVID-19 Infection in the Local Setting |
Flaryll Uong |
| 69 |
[GO] |
2022―Sep―21 |
Poster: ALL-083 Allogeneic Hematopoietic Stem Cell Transplantation of a R/R T-ALL Patient Given Nelarabine, 3 Weeks Post Moderate COVID-19 Infection in the Local Setting |
Flaryll Uong |
| 70 |
[GO] |
2022―Sep―21 |
CT-128 Simple Prognostic Markers in Patients With Hematological Malignancies and COVID-19 Infection: Single-Center Experience |
Nahed Moawad Rakha, Noha Bassiouny, Dalia Abdel-Sattar, Nour Elhuda Hussien |
| 71 |
[GO] |
2022―Sep―21 |
Poster: CT-128 Simple Prognostic Markers in Patients With Hematological Malignancies and COVID-19 Infection: Single-Center Experience |
Nahed Moawad Rakha, Noha Bassiouny, Dalia Abdel-Sattar, Nour Elhuda Hussien |
| 72 |
[GO] |
2022―Sep―21 |
CLL-393 Outcomes of COVID-19 Infections in Patients With Hematological Malignancies in Republic of North Macedonia |
Milche Cvetanoski, Nevenka Ridova, Simona Stojanovska, Lazar Chadievski, Marija Popova Labachevska, Zlate Stojanoski, Aleksandra Pivkova Vlejanovska, Dushko Dukovski, Sanja Trajkova, Milena Grivchevska, Mario Jakimovski, Viktorija Kostojchinoska, Milena Stevanovikj, Ilir Demiri, Tatjana Stojanoska, Ane Milosavljevikj, Irina Panovska Stavridis |
| 73 |
[GO] |
2022―Sep―21 |
ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study |
Odil Giladi, Gianmarco Bagnato, Marianna Gentilini, Shai Shimony, Oren Pasvolsky, Tamar Berger, Gilad Itchaki, Pia Raanani, Alessandro Broccoli, Vittorio Stefoni Stefoni, Ginevra Lolli, Lisa Argnani, Pier Luigi Zinzani, Ronit Gurion |
| 74 |
[GO] |
2022―Sep―21 |
Poster: ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study |
Odil Giladi, Gianmarco Bagnato, Marianna Gentilini, Shai Shimony, Oren Pasvolsky, Tamar Berger, Gilad Itchaki, Pia Raanani, Alessandro Broccoli, Vittorio Stefoni Stefoni, Ginevra Lolli, Lisa Argnani, Pier Luigi Zinzani, Ronit Gurion |
| 75 |
[GO] |
2022―Sep―21 |
CLL-211 Humoral Immune Response Following COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin Lymphoma (NHL): Results From a Large, Single-Center Observational Study |
Frédérique St-Pierre, Peter Doukas, Jennifer Boyer, Mariana Nieves, Shuo Ma |
| 76 |
[GO] |
2022―Sep―21 |
Poster: CLL-211 Humoral Immune Response Following COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin Lymphoma (NHL): Results From a Large, Single-Center Observational Study |
Frédérique St-Pierre, Peter Doukas, Jennifer Boyer, Mariana Nieves, Shuo Ma |
| 77 |
[GO] |
2022―Sep―21 |
IBCL-054 The Effects of an mRNA COVID-19 Vaccine Booster on Immune Responses in Cancer-Bearing Veterans |
Arthur Frankel, Tazio Capozzola, Raiees Andrabi, Chul Ahn, Dennis Burton |
| 78 |
[GO] |
2022―Sep―21 |
CT-157 Another Rare Case of COVID-19 Vaccine Induced Acquired Hemophilia |
Asmaa M. Ismail |
| 79 |
[GO] |
2022―Sep―21 |
CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL |
Antonella Capasso, Elisa Albi, Luana Schiattone, Francesca Martini, Emanuela Sant'Antonio, Lydia Scarfò, Pamela Ranghetti, Michela Frenquelli, Alessandro Campanella, Eleonora Perotta, Silvia Heltai, Maria Colia, Paolo Ghia |
| 80 |
[GO] |
2022―Sep―21 |
Poster: CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL |
Antonella Capasso, Elisa Albi, Luana Schiattone, Francesca Martini, Emanuela Sant'Antonio, Lydia Scarfò, Pamela Ranghetti, Michela Frenquelli, Alessandro Campanella, Eleonora Perotta, Silvia Heltai, Maria Colia, Paolo Ghia |
| 81 |
[GO] |
2022―Sep―21 |
CLL-224 Coronavirus Disease Mortality and Outcome in Macedonian Patients With Chronic Lymphocytic Leukemia: Single-Center Experience |
Sanja Trajkova, Aleksandra Pivkova Veljanovska, Marija Popova Labacevska, Nevenka Ridova, Simona Stojanovska, Dushko Dukovski, Irina Panovska Stavridis |
| 82 |
[GO] |
2022―Sep―21 |
Poster: CLL-224 Coronavirus Disease Mortality and Outcome in Macedonian Patients With Chronic Lymphocytic Leukemia: Single-Center Experience |
Sanja Trajkova, Aleksandra Pivkova Veljanovska, Marija Popova Labacevska, Nevenka Ridova, Simona Stojanovska, Dushko Dukovski, Irina Panovska Stavridis |
| 83 |
[GO] |
2022―Sep―21 |
CML-384 Immunological Response to SARS-CoV-2 After Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - A Prospective Study |
Marisol Miranda Galvis, Danielle Bradshaw, Jaspreet Farmaha, Kimya Jones, Harmanpreet Singh, Ashutosh Vashisht, Nikhil Sahajpal, Ravindra Kolhe, Jorge Cortes |
| 84 |
[GO] |
2022―Sep―21 |
Poster: CML-384 Immunological Response to SARS-CoV-2 After Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - A Prospective Study |
Marisol Miranda Galvis, Danielle Bradshaw, Jaspreet Farmaha, Kimya Jones, Harmanpreet Singh, Ashutosh Vashisht, Nikhil Sahajpal, Ravindra Kolhe, Jorge Cortes |
| 85 |
[GO] |
2022―Sep―21 |
CLL-050 Induction of Neutralizing Antibodies in Chronic Lymphocytic Leukemia Patients After SARS-CoV-2 mRNA Vaccination: A Monocentric Experience |
Fabrizio Mavilia, Federico Pratesi, Claudia Baratè, Edoardo Benedetti, Valentina Guerri, Paola Sammuri, Paola Migliorini, Sara Galimberti |
| 86 |
[GO] |
2022―Sep―21 |
Poster: CLL-050 Induction of Neutralizing Antibodies in Chronic Lymphocytic Leukemia Patients After SARS-CoV-2 mRNA Vaccination: A Monocentric Experience |
Fabrizio Mavilia, Federico Pratesi, Claudia Baratè, Edoardo Benedetti, Valentina Guerri, Paola Sammuri, Paola Migliorini, Sara Galimberti |
| 87 |
[GO] |
2022―Sep―21 |
CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL |
Emily Bryer, Shira Paul, Jonathan Chen, Christopher Pleyer, Adrian Wiestner, Clare Sun |
| 88 |
[GO] |
2022―Sep―21 |
Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL |
Emily Bryer, Shira Paul, Jonathan Chen, Christopher Pleyer, Adrian Wiestner, Clare Sun |
| 89 |
[GO] |
2022―Sep―21 |
CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia |
Andres Chang, Lilin Lai, Akil Akhtar, Susanne Linderman, Victor Orellana-Noia, Manpreet Saini, Rajesh Valanparambil, Kristie Blum, Pamela Allen, Mary Lechowicz, Jason Romancik, Amy Ayers, Colin O'Leary, Michael Churnetski, Melissa Kives, Ajay Nooka, Jean Koff, Madhav Dhodapkar, Mehul Suthar, Jonathon Cohen, Rafi Ahmed |
| 90 |
[GO] |
2022―Sep―21 |
Poster: CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia |
Andres Chang, Lilin Lai, Akil Akhtar, Susanne Linderman, Victor Orellana-Noia, Manpreet Saini, Rajesh Valanparambil, Kristie Blum, Pamela Allen, Mary Lechowicz, Jason Romancik, Amy Ayers, Colin O'Leary, Michael Churnetski, Melissa Kives, Ajay Nooka, Jean Koff, Madhav Dhodapkar, Mehul Suthar, Jonathon Cohen, Rafi Ahmed |
| 91 |
[GO] |
2022―Aug―25 |
P-161: Oral antivirals ritonavir-nirmatrelvir and molnupiravir are highly effective in patients with multiple myeloma and COVID-19; a singlecenter, prospective study |
Vassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Meletios A. Dimopoulos, Evangelos Terpos |
| 92 |
[GO] |
2022―Aug―25 |
P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents |
Ioannis Ntanasis-Stathopoulos, Vangelis Karalis, Maria Gavriatopoulou, Aimilia D Sklirou, Panagiotis Malandrakis, Magdalini Migkou, Maria Roussou, Despina Fotiou, Harry Alexopoulos, Evangelos Eleutherakis-Papaiakovou, Foteini Theodorakakou, Efstathios Kastritis, Ioannis P Trougakos, Meletios A. Dimopoulos, Evangelos Terpos |
| 93 |
[GO] |
2022―Mrz―28 |
COVID-19 mRNA vaccine in patients with lymphoid malignancy or anti-CD20 antibody therapy: a systematic review and meta-analysis |
Yusuke Ito, Akira Honda, Mineo Kurokawa |
| 94 |
[GO] |
2021―Dez―26 |
Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19 |
Michael R. Cook, Kaitlyn Dykes, Katherine White, Sameer Desale, Rajeev Agrawal, Stephen Fernandez, Xu Huang, Nathan K. Cobb, Catherine Lai |
| 95 |
[GO] |
2021―Nov―11 |
COVID-19 vaccine responses in patients with plasma cell dyscrasias after complete vaccination |
Mansi R. Shah, Alissa Gabel, Stephanie Beers, Gratian Salaru, Yong Lin, Dennis L. Cooper |
| 96 |
[GO] |
2021―Nov―10 |
OAB-046: COVID-19 infection in multiple myeloma patients - retrospective analysis of 371 Czech patients |
Jakub Radocha, Ivan Špička, Luděk Pour, Tomas Jelinek, Alexandra Jungova, Jiri Minarik, Adriana Heindorfer, Lukas Stejskal, Jana Ullrychova, Jarmila Obernauerova, Petr Kessler, Marek Wrobel, Petr Pavlíček, Michal Sykora, Peter Mikula, Vladimir Maisnar, Roman Hájek |
| 97 |
[GO] |
2021―Nov―10 |
OAB-045: COVID-19 vaccine responsiveness in patients with Multiple Myeloma and Waldenström Macroglobulinemia |
Andrew Branagan, Matthew Lei, Andrew J. Yee, Elizabeth O’Donnell, Jorge J. Castillo, Noopur Raje, Steven P. Treon, Catherine Flynn, Jill Burke, Cynthia Harrington, Emerentia Agyemang, Clifton Mo, Omar Nadeem, Paul G. Richardson, Allison Maebius, Chukwuamaka Onyewadume, Cristina Panaroni, Kirsten Meid, Zachary Bernstein, Rebecca Lyons, Matthew Waterman, Raquel Gallagher, Boris Juleg, Galit Alter, Shayna Sarosiek |
| 98 |
[GO] |
2021―Nov―10 |
OAB-047: Plasma cell disorder patients are left vulnerable after one dose of the BNT162b2 mRNA or the ChAdOx-nCOV-19 COVID-19 vaccines |
Wei Yee Chan, Lara Howells, William Wilson, Emilie Sanchez, Louise Ainley, Selina Chavda, Emma Dowling, Nuno Correia, Catherine Lecat, Annabel McMillan, Brendan Wisniowski, Shameem Mahmood, Xenofon Papanikolaou, Lydia Lee, Jonathan Sive, Charalampia Kyriakou, Ashutosh Wechalekar, Rakesh Popat, Neil Rabin, Eleni Nastouli, Kwee Yong, Ke Xu |
| 99 |
[GO] |
2021―Nov―10 |
OAB-048: Suboptimal humoral immune response to SARS-CoV-2 mRNA vaccination in myeloma patients is associated with anti-CD38 mAb and BCMA-targeted treatment |
Oliver Van Oekelen, Sarita Agte, Charles Gleason, Komal Srivastava, Katherine Beach, Adolfo Aleman, Bhaskar Upadhyaya, Katerina Kappes, Tarek Mouhieddine, Bo Wang, Ajai Chari, Carlos Cordon-Cardo, Florian Krammer, Sundar Jagannath, Viviana Simon, Ania Wajnberg, Samir Parekh |
| 100 |
[GO] |
2021―Nov―10 |
P-147: COVID-19, impact of vaccination in myeloma patients |
Ellen Hoornaert, François Dachy, Amandine Hansenne, Eugénie Lagneaux, Damien Gruson, Sarah Bailly, Marie Vekemans |
| 101 |
[GO] |
2021―Nov―10 |
P-130: The impact of COVID-19 on the treatment regimens of myeloma and AL amyloidosis patients |
Katie Joyner, Jayne Galinsky, Solène Clavreul |
| 102 |
[GO] |
2021―Nov―10 |
P-143: Breakthrough - a designated pharmacist in the hemato-oncology department improves both quality and sequence of drug treatment and reduces ADR in Multiple Myeloma patients during Covid-19 pandemic |
Areen Alabbasi, Shai Cohen, Manfred Green, Shuli Brammli, Meir Preis, Rasmieh Khalaily |
| 103 |
[GO] |
2021―Nov―10 |
NS-64: Lessons learned: patient management and outcomes of Multiple Myeloma patients during the COVID-19 pandemic in New York City |
Donna Catamero, Oliver Van Oekelen, Tarek Mouhieddine, Bo Wang, Megan Metzger, Joshua Richter, Ajai Chari, Daniel Verina |
| 104 |
[GO] |
2021―Nov―10 |
NP-114: Lesson Learned: Management of patients with Multiple Myeloma (MM) and their response to two doses of COVID-19 RNA vaccine |
Daniel Verina, Oliver Van Oekelen, Charles Gleason, Sarita Agte, Komal Srivastava, Katherine Beach, Adolfo Aleman, Tarek Mouhieddine, Ajai Chari, Carlos Cordon-Cardo, Florian Krammer, Sundar Jagannath, Viviana Simon, Ania Wajnberg, Samir Parekh |
| 105 |
[GO] |
2021―Nov―10 |
P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination |
Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, Despina Fotiou, Eleni-Dimitra Papanagnou, Magdalini Migkou, Foteini Theodorakakou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Ioannis Trougakos, Efstathios Kastritis, Meletios-Athanasios Dimopoulos |
| 106 |
[GO] |
2021―Nov―10 |
P-144: Response to SARS-CoV-2 vaccination in patients with Multiple Myeloma using a 12-week spaced dosing strategy |
Sarah Bird, Aikaterini Panopoulou, Robyn Shea, Micky Tsui, Radovan Saso, Amit Sud, Sharon West, Katy Smith, John Barwood, Ewa Kaczmarek, Carmela Panlaqui, Martin Kaiser, Simon Stern, Kevin Boyd, Charlotte Pawlyn |
| 107 |
[GO] |
2021―Nov―10 |
P-149: Immunogenicity of SARS-CoV-2 vaccine in patients with multiple myeloma |
Florent Malard, Béatrice Gaugier, Joel Gozlan, Lucie Bouquet, Djeneba Fofana, Zoe Van De Wyngaert, Souhila Ikhlef, Zora Marjanovitch, Laurence Morand-Joubert, Mohamad Mohty |
| 108 |
[GO] |
2021―Nov―10 |
NS-63: Adapting and improving a Myeloma Support group during the pandemic |
Emma Dowling, Margareta Sowton, Nuno Correia, Darren Simpson |
| 109 |
[GO] |
2021―Aug―30 |
AML-355: Incidence and Severity of COVID-19 among Inpatients with Hematologic Malignancies |
Natalia Wozniaki, Marcelo Pitombeira Lacerda, JoãoPedro Ribeiro Baptista, Helio Vida Cassi, Gabriela Duarte Neves, Ivan Schneider Boettcher, Ana Claudia Dall’Oglio, Fabiana Sanchez Tavares, Gabriela Roncone Gastal, Fabiano Luis Schwingel |
| 110 |
[GO] |
2021―Aug―30 |
Poster: AML-355: Incidence and Severity of COVID-19 among Inpatients with Hematologic Malignancies |
Natalia Wozniaki, Marcelo Pitombeira Lacerda, JoãoPedro Ribeiro Baptista, Helio Vida Cassi, Gabriela Duarte Neves, Ivan Schneider Boettcher, Ana Claudia Dall’Oglio, Fabiana Sanchez Tavares, Gabriela Roncone Gastal, Fabiano Luis Schwingel |
| 111 |
[GO] |
2021―Aug―30 |
MM-219: Outcome of COVID-19 Among Patients with Multiple Myeloma at the Armenian Hematology Center |
Lusine Sahakyan, Gayane Grigoryan, Yervand Hakobyan |
| 112 |
[GO] |
2021―Aug―30 |
Poster: MM-219: Outcome of COVID-19 Among Patients with Multiple Myeloma at the Armenian Hematology Center |
Lusine Sahakyan, Gayane Grigoryan, Yervand Hakobyan |
| 113 |
[GO] |
2021―Aug―30 |
ABCL-441: Demographic and Quality of Life Model Applications to High-Grade Non-Hodgkin Lymphoma Patients in the COVID-19 Era |
Ayman Youssef, Dalia Nafea, Nahla Hamed, Israa Okap, Amany Abdelbary, Nermeen Afifi, Mostafa Hewalla, Marha Menaisy, Ghada Mohamed, Farida Shaat |
| 114 |
[GO] |
2021―Aug―30 |
Poster: ABCL-441: Demographic and Quality of Life Model Applications to High-Grade Non-Hodgkin Lymphoma Patients in the COVID-19 Era |
Ayman Youssef, Dalia Nafea, Nahla Hamed, Israa Okap, Amany Abdelbary, Nermeen Afifi, Mostafa Hewalla, Marha Menaisy, Ghada Mohamed, Farida Shaat |
| 115 |
[GO] |
2021―Aug―30 |
AML-168: The Assessment of COVID-19 Evolution in Patients with Oncological Diseases Admitted in an Intensive Care Unit of One Romanian Center |
Viola Maria Popov, Lelia Iliescu, Catalina Pirvu, Andra Grigorie, Oana Constantin, Ana Rus, Dana Mihaela Niculae Badoiu, Adriana Badea, Meilin Omer, Mihaela Andreescu |
| 116 |
[GO] |
2021―Aug―30 |
Poster: AML-168: The Assessment of COVID-19 Evolution in Patients with Oncological Diseases Admitted in an Intensive Care Unit of One Romanian Center |
Viola Maria Popov, Lelia Iliescu, Catalina Pirvu, Andra Grigorie, Oana Constantin, Ana Rus, Dana Mihaela Niculae Badoiu, Adriana Badea, Meilin Omer, Mihaela Andreescu |
| 117 |
[GO] |
2021―Aug―30 |
ALL-098: COVID-19 in Children with Cancer: What We Learned from the First Wave |
Fatma Ebeid, Amira Adly, Sara Makkeyah, Salwa Mostafa, Iman Ragab |
| 118 |
[GO] |
2021―Aug―30 |
Poster: ALL-098: COVID-19 in Children with Cancer: What We Learned from the First Wave |
Fatma Ebeid, Amira Adly, Sara Makkeyah, Salwa Mostafa, Iman Ragab |
| 119 |
[GO] |
2021―Aug―30 |
MPN-433: Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: A Single-Institution, Observational Study |
Sami Dwabe, Lakshmi Savitala-Damerla, Abdullah Ladha, Eric Tam, Preet Chaudhary, George Yaghmour |
| 120 |
[GO] |
2021―Aug―30 |
Poster: MPN-433: Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: A Single-Institution, Observational Study |
Sami Dwabe, Lakshmi Savitala-Damerla, Abdullah Ladha, Eric Tam, Preet Chaudhary, George Yaghmour |
| 121 |
[GO] |
2021―Aug―30 |
AML-075: Converting In-Person Research Procedures to a Virtual Platform During the COVID-19 Pandemic in Newly Diagnosed Acute Myeloid Leukemia Patients |
Sara Tinsley, Cecile Lengacher |
| 122 |
[GO] |
2021―Aug―30 |
Poster: AML-075: Converting In-Person Research Procedures to a Virtual Platform During the COVID-19 Pandemic in Newly Diagnosed Acute Myeloid Leukemia Patients |
Sara Tinsley, Cecile Lengacher |
| 123 |
[GO] |
2021―Aug―30 |
ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study |
Annuja Anandaradje, Luxitaa Goenka, Biswajit Dubashi, Smita Kayal, Dhanapati Halanaik, Debdatta Basu, Prasanth Ganesan |
| 124 |
[GO] |
2021―Aug―30 |
Poster: ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study |
Annuja Anandaradje, Luxitaa Goenka, Biswajit Dubashi, Smita Kayal, Dhanapati Halanaik, Debdatta Basu, Prasanth Ganesan |
| 125 |
[GO] |
2021―Aug―30 |
AML-145: Outcomes of Induction Therapy in Patients with Acute Myeloid Leukemia During Covid-19 Pandemic: A Retrospective Study from a Tertiary Care Cancer Centre |
Asif Iqbal, Nithin Daniel, Raghavendra Reddy, Munlima Hazarika |
| 126 |
[GO] |
2021―Aug―30 |
Poster: AML-145: Outcomes of Induction Therapy in Patients with Acute Myeloid Leukemia During Covid-19 Pandemic: A Retrospective Study from a Tertiary Care Cancer Centre |
Asif Iqbal, Nithin Daniel, Raghavendra Reddy, Munlima Hazarika |
| 127 |
[GO] |
2021―Aug―30 |
AML-192: Enhancer of Zeste Homolog 2 (EZH2) in COVID-19-Positive Acute Myeloid Leukemia |
Nahla Hamed, Omar Gallab, Reham Abdelhalim, Mohamed Rezk |
| 128 |
[GO] |
2021―Aug―30 |
ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry |
Olga Gavrilina, Kristina Zakurdaeva, Anastasia Vasileva, Vladimir Vorobyev, Lev Butaev, Vitaly Dubov, Sergey Dubov, Inessa Toropova, Lubov Gavrilova, Marina Popova, Aleksandr Siniaev, Kamil Kaplanov, Andrei Petrenko, Oksana Ochirova, Yulia Sveshnikova, Vasily Shuvaev, Maria Grishunina, Mikhail Kunst, Yulia Chabaeva, Lyubov Al-Radi, Daria Baryshnikova, Elena Gilyazitdinova, Hunan Julhakyan, Valery Savchenko |
| 129 |
[GO] |
2021―Aug―30 |
Poster: ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry |
Olga Gavrilina, Kristina Zakurdaeva, Anastasia Vasileva, Vladimir Vorobyev, Lev Butaev, Vitaly Dubov, Sergey Dubov, Inessa Toropova, Lubov Gavrilova, Marina Popova, Aleksandr Siniaev, Kamil Kaplanov, Andrei Petrenko, Oksana Ochirova, Yulia Sveshnikova, Vasily Shuvaev, Maria Grishunina, Mikhail Kunst, Yulia Chabaeva, Lyubov Al-Radi, Daria Baryshnikova, Elena Gilyazitdinova, Hunan Julhakyan, Valery Savchenko |
| 130 |
[GO] |
2021―Aug―30 |
CT-107: Coronavirus Disease in Bone Marrow Transplant (BMT) Recipients at Edgardo Rebagliati Martins Hospital (HNERM) Lima, Peru |
Susy Bazan, Ruben Rodriguez, Vladimir Espinioza, Alfredo Wong, Melissa Morales-Coloma, Juan Navarro, Lourdes Aranda |
| 131 |
[GO] |
2021―Aug―30 |
Poster: CT-107: Coronavirus Disease in Bone Marrow Transplant (BMT) Recipients at Edgardo Rebagliati Martins Hospital (HNERM) Lima-Peru |
Susy Bazan, Ruben Rodriguez, Vladimir Espinioza, Alfredo Wong, Melissa Morales-Coloma, Juan Navarro, Lourdes Aranda |
| 132 |
[GO] |
2021―Aug―30 |
CML-005: Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with a Donor and Recipient with SARS-CoV-2 Infection |
Gadallah Ali, Majed Altareb, Naeem Chaudhri |
| 133 |
[GO] |
2021―Aug―30 |
ABCL-013: Factors Associated with SARS-CoV-2 Infection and Outcome in Patients with Solid Tumors or Hematological Malignancies: A Single-Center Study |
Anouk Goudsmit, Edouard Cubilier, Anne-Pascale Meert, Philippe Aftimos, Konstantinos Stathopoulos, Chloé Spilleboudt, Angela Loizidou |
| 134 |
[GO] |
2021―Aug―30 |
Poster: ABCL-013: Factors Associated with SARS-CoV-2 Infection and Outcome in Patients with Solid Tumors or Hematological Malignancies: A Single-Center Study |
Anouk Goudsmit, Edouard Cubilier, Anne-Pascale Meert, Philippe Aftimos, Konstantinos Stathopoulos, Chloé Spilleboudt, Angela Loizidou |
| 135 |
[GO] |
2021―Jul―26 |
Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country |
Mahmoud Hammad, Lobna Shalaby, Iman Sidhom, Nancy Sherief, Ibrahim Abdo, Sonia Soliman, Youssef Madeny, Reem Hassan, Shaimaa Elmeniawy, Nagwa Khamis, Iman Zaki, Tarek Mansour, Mohamed Gamal El-Ansary, Ahmed El-Halfawy, Sherif Abouelnaga, Alaa Elhaddad |
| 136 |
[GO] |
2021―Jul―18 |
Resolution of one-year persisting COVID-19 pneumonia and development of immune thrombocytopenia in a follicular lymphoma patient with preceding rituximab maintenance therapy: a follow-up report and literature review of cases with prolonged infections |
Hajime Yasuda, Yosuke Mori, Asako Chiba, Jie Bai, Goh Murayama, Yasushi Matsushita, Sachiko Miyake, Norio Komatsu |
| 137 |
[GO] |
2021―Jul―18 |
Frequency, clinical characteristics and outcome of adults with acute lymphoblastic leukemia and COVID 19 infection in the first vs. second pandemic wave in Spain |
Josep-Maria Ribera, Mireia Morgades, Rosa Coll, Pere Barba, Jose-Luis López-Lorenzo, Pau Montesinos, María-Angeles Foncillas, Mónica Cabrero, Ignacio Gómez-Centurión, María-Dolores Morales, María-Rosario Varela, Pilar Herrera, Irene García-Cadenas, María Calbacho, Anna Torrent, Clara Maluquer, Marisa Calabuig, Antoni Garcia-Guiñon, Guiomar Bautista, Laura Llorente, Cristina Gil, María-Teresa Artola, José González-Campos, Ainhoa Fernández-Moreno, Abelardo Bárez, Teresa Giménez-Pérez, Juan Bergua, María-José Sánchez-Sánchez, María-Carmen Mateos, José-Luis Piñana |
| 138 |
[GO] |
2021―Mai―31 |
COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic |
Martin Čerňan, Tomáš Szotkowski, Aleš Obr, Vojtěch Látal, Antonín Hluší, Petra Krhovská, Olga Klementová, Milan Kolář, Pavel Sauer, Edgar Faber, Tomáš Fürst, Tomáš Papajík |
| 139 |
[GO] |
2021―Mai―21 |
DRAMATIC RESPONSE TO CONVALESCENT HYPERIMMUNE PLASMA IN ASSOCIATION WITH AN EXTENDED COURSE OF REMDESIVIR IN FOUR B-CELL DEPLETED NON HODGKIN LYMPHOMA PATIENTS WITH SARS-COV-2 PNEUMONIA AFTER RITUXIMAB THERAPY |
Anna Furlan, Gabriella Forner, Ludovica Cipriani, Elisa Vian, Roberto Rigoli, Filippo Gherlinzoni, Piergiorgio Scotton |
| 140 |
[GO] |
2021―Feb―27 |
Delayed COVID-19 Respiratory Failure in Lymphoma Patients on Rituximab-based Chemoimmunotherapy |
Marc S Hoffmann, Siddhartha Ganguly |
| 141 |
[GO] |
2021―Jan―14 |
Severe and irreversible pancytopenia associated with SARS-CoV-2 bone marrow infection in a Waldenstrom’s Macroglobulinemia patient |
Mélanie Velier, Stéphane Priet, Romain Appay, Thérèse Atieh, Hubert Lepidi, Gilles Kaplanski, Pierre André Jarrot, Marie Koubi, Régis Costello, Françoise Dignat-George, Xavier DE. Lamballerie, Antoine Tichadou, Robin Arcani, Anne Laure Couderc, Julian Touati, Arthur Varoquaux, Yaël Berda-Haddad, Geoffroy Venton |
| 142 |
[GO] |
2021―Jan―14 |
Treatment of Acute Leukemia during COVID-19: Focused review of evidence |
Suvir Singh, Jagdeep Singh, Davinder Paul, Kunal Jain |
| 143 |
[GO] |
2020―Dez―10 |
ABCL-093: The Single-Center Analysis of Survival and Mortality in Patients with Hematological Diseases and COVID-19 in Russia |
Olga Gavrilina, Tatyana Gaponova, Vera Troitskaya, Elena Parovichnikova, Gennadiy Galstyan, Karen Danishyan, Anton Luchkin, Zalina Fidarova, Tatyana Tupoleva, Dmitriy Tikhomirov, Elena Sysoeva, Yana Mangasarova, Eugine Zvonkov, Elena Gribanova, Alexey Anikin, Hunan Julhakyan, Olga Sivakova, Oleg Mil'ko, Grigoriy Efimov, Sergey Boitsov, Valeriy Savchenko |
| 144 |
[GO] |
2020―Dez―10 |
AML-335: Treating Hematologic Oncology Patients in the Developing World During the COVID-19 Pandemic |
Liana Hambardzumyan, Maria Badikyan, Hayk Grigoryan, Artashes Tadevosyan, Tatevik Grigoryan, Nare Martirosyan, Miranush Saaryan, Armine Farmazyan, Yervand Hakobyan, Karen Meliksetyan, Samvel Danielyan, Gevorg Tamamyan |
| 145 |
[GO] |
2020―Dez―10 |
CT-365: The Evaluation of Haematological and Biochemistry Parameters in COVID-19 Patients as a Predictive Factor for Unfavourable Evolution |
Viola Popov, Lelia Iliescu, Marius loan Balea, Mihaela Andreescu, Mihaela Popescu, Oana Patrinoiu, Geanina Ofiteru, Claudia Despan, Meilin Omer, Silvia Ion, Marius Lucian Aurel Balea, Catalina Parvu, Oana Constantin, Jeanina Valcea, Adriana Badea, Ana Rus, Mihaela Niculae, Andreea Calen, Andra Grigorie, Valentin Nedelcu, Daniela Gologanu, Daniela Georgescu |
| 146 |
[GO] |
2020―Dez―10 |
MM-239: A Tertiary Center Experience of Multiple Myeloma Patients with COVID-19: Lessons Learned and the Path Forward |
Bo Wang, Oliver Van Oekelen, Tarek Mouhieddine, Sundar Jagannath, Samir Parekh, Deepu Madduri |
| 147 |
[GO] |
2020―Dez―10 |
CLL-370: The Prolonged Positivity of SARS-CoV-2 RNA in Chronic Lymphocytic Leukemia Patients |
Viola Popov, Mihaela Andreescu, Oana Patrinoiu, Mihaela Popescu, Claudia Despan, Meilin Omer, Felicia Mihai, Geanina Ofiteru, Marius Lucian Balea, Silvia Ion, Daniela Georgescu |
| 148 |
[GO] |
2020―Dez―10 |
CT-152: Application of Web-Scraping Techniques for Autonomous Massive Retrieval of Hematologic Patients' Information During SARS-CoV2 Pandemic |
Raul Azibeiro Melchor, Marta Fonseca, Beatriz Rey, Alberto Hernandez, Borja Puertas, Sandra Gomez, Danylo Palomino, Luz Gema Román, Andres Felipe Peña, Maria Victoria Mateos |
| 149 |
[GO] |
2020―Dez―10 |
MPN-182: Transfusion in Hematology Patients During the COVID19 Pandemic: A Systematic Review |
Marcel Massoud, Christelle El Riachy |
| 150 |
[GO] |
2020―Aug―22 |
Persistent covid-19 pneumonia and failure to develop anti-SARS-CoV-2 antibodies during rituximab maintenance therapy for follicular lymphoma |
Hajime Yasuda, Yutaka Tsukune, Naoki Watanabe, Kazuya Sugimoto, Ayana Uchimura, Misa Tateyama, Yosuke Miyashita, Yusuke Ochi, Norio Komatsu |
| 151 |
[GO] |
2020―Jun―25 |
Successful use of COVID-19 convalescent plasma in a patient recently treated for follicular lymphoma |
Zachary Wright, Adrian Bersabe, Rina Eden, Andrew Cap |
| 152 |
[GO] |
2020―Jun―25 |
Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant patient on Ruxolitinib |
Francine M. Foss, Ami Rubinowitz, Marie L. Landry, Iris Isufi, Lohith Gowda, Stuart Seropian, Sarah Perreault, Sheela V. Shenoi |
|
